These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2354252)

  • 1. [Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology].
    Baltali E; Souadka A; el Hafed A; Wydadi M; Kettani F; Alamy H; el Gueddari B; Morchid M; Bouih A; Souadka F
    Bull Cancer; 1990; 77(4):363-9. PubMed ID: 2354252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma.
    Prost O; Turrel MO; Dahan N; Craveur C; Adessi GL
    Cancer Res; 1984 Feb; 44(2):661-4. PubMed ID: 6581863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen value as a marker in breast cancer.
    Narita D; Cimpean AM; Anghel A; Raica M
    Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of borderline HER-2/neu breast carcinoma: a biologically distinct phenotype.
    Killeen JL; Ortega-Lopez A; Shaha J; Shaha SH; Fu JB
    Breast Cancer Res Treat; 2006 Jul; 98(1):99-108. PubMed ID: 16538540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the nutritional status and tumor characteristics in premenopausal and postmenopausal breast cancer patients.
    Vasiljević N; Pecelj-Gec M; Jorga J; Nikolić-Vukosavljević D; Branković-Magić M; Marinković J; Mitrović L
    Neoplasma; 1998; 45(6):389-94. PubMed ID: 10210115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of apolipoprotein D in breast cancer.
    Díez-Itza I; Vizoso F; Merino AM; Sánchez LM; Tolivia J; Fernández J; Ruibal A; López-Otín C
    Am J Pathol; 1994 Feb; 144(2):310-20. PubMed ID: 8311115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Gynecol Endocrinol; 2009 Mar; 25(3):183-7. PubMed ID: 19347708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease.
    Reed MJ; Cheng RW; Noel CT; Dudley HA; James VH
    Cancer Res; 1983 Aug; 43(8):3940-3. PubMed ID: 6683128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital.
    Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
    Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomas.
    Meduri G; Charnaux N; Spyratos F; Hacene K; Loosfelt H; Milgrom E
    Cancer; 2003 Apr; 97(7):1810-6. PubMed ID: 12655539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptor alpha and progesterone receptor in normal human breast epithelium.
    Umekita Y; Souda M; Ohi Y; Rai Y; Sagara Y; Sagara Y; Yoshida H
    In Vivo; 2007; 21(3):535-9. PubMed ID: 17591366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of invasive breast cancer and ductal carcinoma in situ in a screening program by age: should older women continue screening?
    Erbas B; Amos A; Fletcher A; Kavanagh AM; Gertig DM
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1569-73. PubMed ID: 15466971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A relationship between estrogen sulfurylation and estrogen and progesterone receptor status in human mammary carcinoma.
    Pewnim T; Adams JB; Ho KP
    Cancer Res; 1980 Apr; 40(4):1360-2. PubMed ID: 6928401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.